| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/12/2004 | WO2003020906A3 Multivalent protein conjugate with multiple ligand-binding domains of receptors |
| 02/12/2004 | WO2003014365A3 Plant glycogenin homologs and use thereof in starch modification |
| 02/12/2004 | WO2003014325A3 Protein design automation for protein libraries |
| 02/12/2004 | WO2003014150A9 Fusion proteins for insect control |
| 02/12/2004 | WO2003012041A3 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/12/2004 | WO2003012036A3 Systems for in vivo site-directed mutagenesis using oligonucleotides |
| 02/12/2004 | WO2003011213A3 Method for treating diabetes and obesity |
| 02/12/2004 | WO2003010282A3 Interleukin-1 beta antibodies |
| 02/12/2004 | WO2003008975A3 Biochip and the production method thereof |
| 02/12/2004 | WO2003008587A3 A lactococcus gene, the amylolytic enzyme it encodes and its application |
| 02/12/2004 | WO2003008585A3 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development |
| 02/12/2004 | WO2003004656A8 Method for obtaining cells with new properties |
| 02/12/2004 | WO2003000897A8 Identification and characterization of phosphate transporter genes |
| 02/12/2004 | WO2002103363A3 Selection by avidity capture |
| 02/12/2004 | WO2002101357A9 Molecular signatures of commonly fatal carcinomas |
| 02/12/2004 | WO2002101057A8 Gene transfer into primate embryonic stem cells using vsv-g pseudo type simian immunodeficiency virus vector |
| 02/12/2004 | WO2002097082A3 Engineered biosynthesis of novel polyenes |
| 02/12/2004 | WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules |
| 02/12/2004 | WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 02/12/2004 | WO2002081623A3 Cell cycle nucleic acids, polypeptides and uses thereof |
| 02/12/2004 | WO2002081507A3 Interferon gamma polypeptide variants |
| 02/12/2004 | WO2002080848A3 Methods and materials for cancer treatment |
| 02/12/2004 | WO2002077895A3 Method for epigenetic feature selection |
| 02/12/2004 | WO2002077232A3 Compositions and methods relating to breast specific genes and proteins |
| 02/12/2004 | WO2002076507A3 Uses of opg ligand to modulate immune responses |
| 02/12/2004 | WO2002070650A3 Dynamic whole genome screening methodology and systems |
| 02/12/2004 | WO2002068649A3 Proteins and nucleic acids encoding same |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002064824A3 Oligonucleotide probes used to detect parodontopathogenic bacteria by in situ hybridization |
| 02/12/2004 | WO2002064747A3 Fusion proteins based upon somatostatin receptors |
| 02/12/2004 | WO2002062953A3 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1 |
| 02/12/2004 | WO2002062952A3 Non-cytotoxic pap mutants |
| 02/12/2004 | WO2002061045A3 Simplified method for indexing and determining the relative concentration of expressed messenger rnas |
| 02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 02/12/2004 | WO2002059333A3 Gene promoters isolated from potato and use thereof |
| 02/12/2004 | WO2002059299A3 Expression cloning method |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution |
| 02/12/2004 | WO2002055702A3 Human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | WO2002052046A3 Oligonucleotide transfection screening method |
| 02/12/2004 | WO2002046411A3 Intestinal proteins |
| 02/12/2004 | WO2002046390A3 Transgenic mice containing rptpb tyrosine phosphatase gene disruptions |
| 02/12/2004 | WO2002045495A3 Transgenic mice containing targeted gene disruptions |
| 02/12/2004 | WO2002045493A3 Transgenic mice containing phosphatase target gene disruptions |
| 02/12/2004 | WO2002045491A3 Transgenic mice containing protease target gene disruptions |
| 02/12/2004 | WO2002040686A3 Expression system for recombinant proteins |
| 02/12/2004 | WO2002034893A3 Synthetic viruses and uses thereof |
| 02/12/2004 | WO2001064926A8 Methods and compositions to reduce or eliminate transmission of a transgene |
| 02/12/2004 | US20040031076 Using Agrobacterium-mediated transformation of a plant tissue explant, subsequent regeneration of the transformed cells into whole Camelina sativa plants |
| 02/12/2004 | US20040031075 Method of accumulating foreign gene product in plant seed at high level |
| 02/12/2004 | US20040031074 Isolated from tobacco, recombinant nucleic acids containing the same, expression vectors and transgenic plants produced therewith |
| 02/12/2004 | US20040031073 Method for modifying plant morphology, biochemistry and physiology |
| 02/12/2004 | US20040031070 RNA transfection of sperm cells |
| 02/12/2004 | US20040031069 Cloning endangered and extinct species |
| 02/12/2004 | US20040031067 Compositions and methods for preparing vascularized dermal reconstructs, vascularized skin grafts, and for enhancing vascularization in situ in response to a variety of medical conditions |
| 02/12/2004 | US20040031065 Neuronal activation in a transgenic model |
| 02/12/2004 | US20040030118 Methods for regulating hematopoiesis using CpG-oligonucleotides |
| 02/12/2004 | US20040030117 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 02/12/2004 | US20040030116 Used in identification of microorganisms which can be used to produce fine chemicals, the modulation of fine chemical production in C. glutamicum or related bacteria, the typing or identification of C. glutamicum as transformation markers |
| 02/12/2004 | US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them |
| 02/12/2004 | US20040030114 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040030110 Novel proteins and nucleic acids encoding same |
| 02/12/2004 | US20040030100 For preventing, ameliorating, or correcting dysfunctions or diseases including obesity and diseases related to obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, compulsive disorders, schizophrenia, |
| 02/12/2004 | US20040030099 Regulation of human patched-like protein |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029827 Remedies for heart failure |
| 02/12/2004 | US20040029823 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins |
| 02/12/2004 | US20040029822 Detecting moderator of human chromosomes; calibration; genetic engineering; screening for nervous system defects in mammals |
| 02/12/2004 | US20040029808 Binding antibody to estradiol; test device |
| 02/12/2004 | US20040029793 Genetic engineering; antibodies; antiinflammatory agents, circulation diseases, anticancer agents, antidiabetic agents, gastrointestinal disorders |
| 02/12/2004 | US20040029791 Polypeptides; antitumor agents; suppression phosphorylation |
| 02/12/2004 | US20040029770 Genetic engineering; anticancer agents |
| 02/12/2004 | US20040029283 Intron double stranded RNA constructs and uses thereof |
| 02/12/2004 | US20040029282 A promoter derived from an Arabidopsis ATP sulfurase gene, nucleic acid constructs, vectors, plant cells and transgenic plants comprising the promoter |
| 02/12/2004 | US20040029280 Viral vectors with modified tropism |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029278 Recombinant alphaviruses which are capable of expressing a heterologous sequence in target cells |
| 02/12/2004 | US20040029277 Oligonucleotides specifically hybridizable with nucleic acids encoding Nitrogen Assimilation Control (NAC); for treating hyperproliferative disease, neurological disorders and aberrant apoptosis |
| 02/12/2004 | US20040029275 Short interfering RNA (siRNAs); reducing expression by obtaining and introducing into a cell multiple single or double stranded RNAs (dsRNAs) or DNA constructs capable of expressing multiple siRNAs in cells |
| 02/12/2004 | US20040029274 Antisense modulation of EDG5 expression |
| 02/12/2004 | US20040029273 Endothelial differentiation gene 1 (EDG1); using antisense compounds for modulation of EDG1 expression and for treatment of diseases associated with expression of EDG1 |
| 02/12/2004 | US20040029260 A fully automated and integrated system that comprises a pipetter, extractor and an assay reader |
| 02/12/2004 | US20040029258 Methods and devices for performing chemical reactions on a solid support |
| 02/12/2004 | US20040029256 Genetically modified Kluyveromyces cells, methods for making them, and their use in production of organic products, particularly D-lactic acid |
| 02/12/2004 | US20040029255 The use of primers to detect specific isolates of fungal pathogens and the monitoring of disease development in plants; Colletotrichum acutatum, Alternaria spp., and Cladosporium carpophilum |
| 02/12/2004 | US20040029252 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 02/12/2004 | US20040029251 Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029245 Used in preventing, ameliorating, or correcting dysfunctions or diseases including cancer, diabetes, and obesity |
| 02/12/2004 | US20040029241 Formulation and use of a polymerization process employing biocompatible polymers and biocompatible polymerization conditions, such as neutral pH, where there is maintenance of an aqueous environment |
| 02/12/2004 | US20040029239 comprising creating a recombinant obtained by transferring into a host a recombinant DNA for expression or a DNA fragment for genomic integration |
| 02/12/2004 | US20040029238 Recombinant yeast cells, methods for culturing yeast cells, nucleic acid constructs |
| 02/12/2004 | US20040029234 Enhanced 2-keto-l-gulonic acid production |
| 02/12/2004 | US20040029232 Novel G-protein coupled receptors |
| 02/12/2004 | US20040029231 Mutant E.coli strains, and their use for producing recombinant polypeptides |
| 02/12/2004 | US20040029229 High level protein expression system |